On January 13, 2020, H.C. Wainwright initiates coverage On CEL-SCI to Buy with a PT of $18.
Who doesn't want a 237% gain!!!??
Skeptics might say this means an offering is pending. Two counter points to this: 1) CEL-SCI has plenty of cash until the end of the trial (see discussion below) and 2) the recent offering had a 45 day Lock-Up clause. Thus, no offering can occur for 45 days after the secondary closed. While we do not expect another offering until after data is released, one can't occur before February 10, 2020.
Why is a small Biotech with limited cash resources hiring manufacturing positions? Why would they incur the costs to hire, train and pay new employees at this juncture?
Why would they need to turn on the Cold Fill manufacturing facility and start producing Multikine?
This is not normal...This is BULLISH!!!!!
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise." - Peter Lynch
On 1/13, Geert buys another $50K! (hint hint. wink wink)
On 10/25, Geert bought another $25K!
On 9/4, the Geert and 2 others purchased another $57K.
On 6/3, Geert bought MORE! He bought another $25K
On 5/7, Geert "purchased another $100,000 worth of restricted CEL-SCI stock at $6.86 directly from the Company at the full market price. Several others from our senior management team and one member of the Board of Directors have joined Geert and purchased another $110,000 worth of CEL-SCI stock on the same terms. "
Furthermore, on 5/21 Peter Young bought another $10K on the open market.
All Insider Transactions can be seen here.
Why has CEL-SCI contracted with The Petrizzo Group to lobby the FDA/US Government about "FDA approval issues of innovative drug therapies"?
Why spend $100K when cash flow is low?
They lobbied the U.S. Senate, the U.S. House of Reps, the FDA, the Office of Management and Budget and Health & Human Services.
The IDMC made the following recommendation on October 15, 2019
The subsequent 8-K said it more succinctly:
READ ABOUT THE IDMC HERE
Wow! Just wow.
Geert has removed the biggest question mark: when and how bad is the offering going to be!
A clean deal! No warrants. Low discount. And 15% Greenshoe!
$6M. They now have over $14M... Enough money until end of Trial.
The Vulture Shorts were waiting and hoping for toxic financing to save their asses! F' Them!
Now, there is NO excuse for people to jump into the stock.
Open/Close "print" trades and Form T trades are very common for CVM. But what isn't "normal" is the recent uptick in the volume/size of these trades.
I was slow to start tracking, but started tracking Opening/Closing trades and any material after hours trades a few weeks ago. These trades happening "outside: of normal trading" is done for many reasons. Reduce volatility and accumulate on the "down low".
But this I know:
Since I started tracking, someone(s) has purchased almost $12M worth of shares.
On 9/25, Ergomed released their Interim financial results. In this presentation, they state the following:
96% complete...not 95% or "First Half of 2019" (like their prior presentation), but 96%. Why not 95%?
This implies we are at 286 Events! FOSCO is RIGHT!!!!
******BUT WAIT!!! Shortly after posting this all over the internet, the Interim Presentation was REMOVED and UPDATED. It no longer mentions "96% Complete".
Don't worry, your pal Sushi kept a copy here!
Why did they remove 96%? Because they fucked up and accidentally released CONFIDENTIAL info. That's why!
READ THE AMAZING ARTICLE BELOW
Andybo from StockTwits brought this to our attention. Someone bought out the domain name Multikine.com on Friday, Sept 13 before the expiration date, meaning, someone paid $ to buy out the domain from the old owner. Why now? Why days before the IDMC did this happen?
Who is the new owner? Multikine.com doesn't redirect to the Cel-Sci.com website....
While we dont know now, time will tell. Things like this are called "HINTS"
Dr Miroslav Reljanovic, Executive Chairman of the Company, purchased 200K shares ($775K USD) on 6/24. Add this to the recent purchases by the COO and CFO brings the total to over $1.2M USD of Insider transactions in the past weeks.
Insider transactions details HERE
For a Deep Dive on the Ergomed and CEL-SCI relationship, please read this Article HERE
Copyright © 2019 Killcvmshorts - All Rights Reserved. NOT AFFILIATED WITH CEL-SCI IN ANY CAPACITY! THIS WEBSITE SHOULD NOT BE CONSIDERED INVESTMENT ADVICE. WEBSITE CREATED BY A NUT JOB WITH TOO MUCH TIME ON HIS HANDS. THIS NUT JOB HAS SHARES OF CVM AND IS LONG. THIS NUT JOB ISNT BEING COMPENSATED FOR THIS SITE. THIS NUT JOB NEVER HAS BEEN COMPENSATED FOR ANY OF MY DUE DILIGENCE OR WORK RELATED TO CVM. ALL THESE OPINIONS ARE OF A NUT JOB.
Powered by GoDaddy Website Builder